Lincoln Pharmaceuticals quarterly results and financials

Lincoln Pharmaceuticals (LINCOLN)₹520.85+1.39%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Lincoln Pharmaceuticals reported sales of ₹191 Cr, up 17.3% from Sep 2025, and net profit of ₹20.09 Cr, up 0.0% year on year. For the year to Mar 2026, sales were ₹672 Cr and net profit ₹88.33 Cr.

Sales (Sep 2026): ₹191 Cr
Net profit (Sep 2026): ₹20.09 Cr
Sales (FY Mar 2026): ₹672 Cr
Net profit (FY Mar 2026): ₹88.33 Cr
EPS (Sep 2026): ₹10.21
Borrowings (Mar 2026): ₹4.01 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Lincoln Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Lincoln Pharmaceuticals Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	146	142	147	161	147	168	154	163	166	187	177	191
Expenses	117	124	125	133	123	141	130	138	143	162	150	168
Operating Profit	29.98	18.01	22.99	28.02	23.99	26.98	24.01	25.02	23.98	25.01	26.99	24.02
OPM %	19.9%	12.9%	14.9%	17.9%	15.9%	15.9%	14.9%	15.9%	14.0%	12.9%	14.9%	11.9%
Other Income	11.03	7.02	10.02	10.01	9.02	−7.01	15.02	7.02	15.03	−4.01	24.04	10.02
Interest	0.00	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	3.01	3.01	2.99	3.01	3.01	3.01	3.01	4.01	3.99	4.01	4.01	3.99
Profit before tax	37.98	21.96	28.98	34.95	28.98	15.98	34.98	28.95	34.96	16.98	47.90	28.97
Tax %	26.0%	16.1%	20.0%	24.0%	28.0%	29.0%	22.0%	31.1%	18.0%	30.1%	24.1%	30.1%
Net Profit	28.10	19.06	24.07	26.08	21.10	12.04	28.09	20.08	29.11	12.04	36.12	20.09
EPS (Rs)	14.01	9.30	11.81	13.16	10.38	5.79	13.83	9.99	14.27	5.82	18.10	10.21

Lincoln Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Lincoln Pharmaceuticals Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	401	361	362	366	387	424	473	511	582	624	672	722
Expenses	359	313	308	299	321	337	376	421	480	522	573	623
Operating Profit	40.97	47.04	53.01	67.97	65.97	87.06	96.04	89.97	100	102	98.02	100
OPM %	9.9%	12.9%	14.9%	17.9%	16.9%	20.9%	19.9%	17.9%	16.9%	15.9%	14.9%	13.9%
Other Income	7.01	2.01	5.01	5.01	11.02	5.01	10.02	22.03	34.08	22.03	33.08	45.08
Interest	10.03	7.03	5.02	4.02	2.01	2.01	1.01	2.01	1.01	2.01	1.01	0.00
Depreciation	5.01	6.01	6.01	7.01	7.01	8.01	8.01	9.01	11.01	13.02	14.01	16.00
Profit before tax	32.95	36.94	45.94	61.95	66.92	83.89	95.90	99.90	122	109	116	129
Tax %	28.1%	25.1%	25.1%	22.1%	23.0%	26.1%	28.0%	27.1%	24.1%	25.0%	24.1%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.99	0.00	0.99	1.99	1.99	—
Net Profit	24.10	28.11	35.15	49.16	51.18	62.28	69.32	73.26	93.29	82.27	88.33	97.36
EPS (Rs)	14.54	14.08	17.30	24.37	25.75	31.14	34.64	36.44	46.62	41.16	43.90	48.40
Dividend payout %	7.0%	9.0%	9.1%	6.0%	6.0%	5.0%	4.0%	4.0%	4.0%	4.0%	4.0%	—

Lincoln Pharmaceuticals balance sheet

₹ crore, at each year end.

Lincoln Pharmaceuticals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16.02	16.03	20.02	20.01	20.03	20.03	20.01	20.02	20.01	20.01	20.01	20.02
Reserves	94.86	124	172	204	249	293	346	413	482	573	652	737
Borrowings	76.07	78.10	64.06	61.08	34.06	5.01	1.01	2.01	2.01	1.01	0.00	4.01
Other Liabilities	70.19	56.11	48.19	62.21	63.13	71.34	85.21	99.38	83.40	106	125	129
Total Liabilities	258	275	305	347	366	389	452	534	587	700	797	890
Fixed Assets	66.03	98.04	103	117	121	123	111	132	151	179	182	191
CWIP	2.99	2.99	6.98	0.00	1.99	0.00	1.99	15.94	6.97	2.99	3.98	4.98
Investments	0.00	0.00	9.96	10.97	17.95	33.87	80.79	96.62	90.78	139	173	208
Other Assets	190	174	186	219	225	232	259	290	339	380	437	486
Inventories	21.99	26.99	36.97	44.99	35.98	46.98	47.01	72.91	69.98	76.92	78.95	79.99
Trade receivables	119	80.75	90.64	109	121	101	113	115	135	161	165	161
Cash & equivalents	11.99	13.01	12.01	14.99	7.99	14.98	13.99	19.01	33.97	13.99	21.99	32.96
Total Assets	258	275	305	347	366	389	452	534	587	700	797	890

Lincoln Pharmaceuticals cash flow

₹ crore, for each year.

Lincoln Pharmaceuticals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	24.97	44.94	24.97	26.96	52.99	74.98	68.88	75.93	38.94	62.94	92.95	106
Cash from investing activity	6.99	−41.92	−24.97	−11.98	−17.97	−30.99	−63.93	−77.94	−36.98	−56.91	−78.94	−97.92
Cash from financing activity	−32.02	−2.99	0.00	−11.01	−36.03	−37.99	−5.99	−2.99	−3.99	−4.99	−5.99	0.00
Net cash flow	−0.99	0.00	0.00	2.99	−0.99	6.97	−0.99	−3.98	−1.99	0.99	7.97	7.97
Capex	3.99	33.91	17.96	9.99	14.97	7.98	8.99	45.90	13.97	39.91	18.97	25.94
Free cash flow	21.07	11.04	7.02	17.05	38.13	68.26	61.18	31.08	26.10	24.09	74.18	82.20
CFO / OP %	109.0%	126.0%	73.9%	68.0%	103.9%	137.0%	102.0%	103.9%	77.0%	88.9%	117.0%	135.0%

Lincoln Pharmaceuticals ratios

Working-capital days and returns, by year.

Lincoln Pharmaceuticals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	162	72	91	110	121	95	97	89	97	101	96	87
Inventory days	44	36	63	86	75	95	86	121	106	101	99	94
Days payable	91	39	53	81	91	101	104	119	76	94	105	99
Cash conversion cycle	117	71	101	116	107	89	79	92	127	109	91	83
Working capital days	76	31	69	89	113	126	119	113	121	121	116	126
ROCE %	15.1%	21.1%	19.1%	19.0%	23.1%	22.1%	25.0%	24.0%	22.0%	22.0%	17.1%	16.0%

Lincoln Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Lincoln Pharmaceuticals?

For the Sep 2026 quarter, Lincoln Pharmaceuticals reported sales of ₹191 Cr, up 17.3% year on year and net profit of ₹20.09 Cr, up 0.0% year on year. The operating margin was 11.9%.

What is the annual revenue of Lincoln Pharmaceuticals?

Lincoln Pharmaceuticals' sales for the year to Mar 2026 were ₹672 Cr; over the last twelve months they were ₹722 Cr.

What is the net profit of Lincoln Pharmaceuticals?

Net profit for the year to Mar 2026 was ₹88.33 Cr, and ₹97.36 Cr over the last twelve months. Earnings per share over the same trailing period were ₹48.40.

How much debt does Lincoln Pharmaceuticals have?

Lincoln Pharmaceuticals reported borrowings of ₹4.01 Cr at Mar 2026, against cash and equivalents of ₹32.96 Cr.

What is the free cash flow of Lincoln Pharmaceuticals?

Cash from operations was ₹106 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹82.20 Cr.

Loading…